Impairment of habituation of the auditory brain stem response in migrainous vertigo

Annals of Otology, Rhinology and Laryngology

Volumn 122, Issue 5, 2013, Pages 308-315

  Brodsky, Jacob R ^a,b   Mejico, Luis J ^a   Giraud, Andrew ^a   Woods III, Charles I ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Auditory Brain Stem Response; Migraine; Vertigo; Vestibular Migraine

Indexed keywords

ACETAZOLAMIDE; AMITRIPTYLINE; ATENOLOL; CLONAZEPAM; HYDROCODONE; IBUPROFEN; MAGNESIUM OXIDE; MECLOZINE; ONDANSETRON; PARACETAMOL; RIBOFLAVIN; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE;

ARTICLE; BRAIN STEM; BRAIN STEM RESPONSE; CASE REPORT; CONTROLLED STUDY; DIZZINESS; DORSAL RAPHE NUCLEUS; FEMALE; HABITUATION; HUMAN; INFERIOR COLLICULUS; MALE; MIGRAINE; MIGRAINOUS VERTIGO; NAUSEA; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; QUESTIONNAIRE; SPEECH DISORDER; SYMPTOM; VERTIGO; VOMITING;

EID: 84877764720     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941312200504     Document Type: Article

References (31)

1. Lempert T, Neuhauser H. Migrainous vertigo. Neurol Clin 2005;23:715-30.
2. Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001;56:436-41.
3. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(suppl 1):9-160.
4. Neuhauser HK, Radtke A, von Brevern M, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology 2006;67:1028-33.
5. Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology 2003;60:882-3.
6. Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain 2011;12:81-8.
7. Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 1997;18:350-4.
8. Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 2002;23:364-71.
9. Bisdorff AR. Treatment of migraine related vertigo with lamotrigine: an observational study. Bull Soc Sci Med Grand Duche Luxemb 2004;2:103-8.
10. Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope 1998;108:1-28.
11. von Brevern M, Zeise D, Neuhauser H, Clarke AH, Lempert T. Acute migrainous vertigo: clinical and oculographic findings. Brain 2005;128:365-74.
12. Celebisoy N, Gökçay F, Sirin H, Biçak N. Migrainous vertigo: clinical, oculographic and posturographic findings. Cephalalgia 2007;28:72-7.
13. Teggi R, Colombo B, Bernasconi L, Bellini C, Comi G, Bussi M. Migrainous vertigo: results of caloric testing and stabilometric findings. Headache 2009;49:435-44.
14. Baier B, Dieterich M. Vestibular-evoked myogenic potentials in "vestibular migraine" and Menière's disease: a sign of an electrophysiological link? Ann N Y Acad Sci 2009;1164: 324-7.
15. Jeong SH, Oh SY, Kim HJ, Koo JW, Kim JS. Vestibular dysfunction in migraine: effects of associated vertigo and motion sickness. J Neurol 2010;257:905-12.
16. Marano E, Marcelli V, Di Stasio E, et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache 2005;45:325-31.
17. Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 2003;16:5-13.
18. Koo JW, Balaban CD. Serotonin-induced plasma extravasation in the murine inner ear: possible mechanism of migraineassociated inner ear dysfunction. Cephalalgia 2006;26:1310-9.
19. Sand T, Zhitniy N, White LR, Stovner LJ. Brainstem auditory-evoked potential habituation and intensity-dependence related to serotonin metabolism in migraine: a longitudinal study. Clin Neurophysiol 2008;119:1190-200.
20. Sand T, Vingen JV. Visual, long-latency auditory and brainstem auditory evoked potentials in migraine: relation to pattern size, stimulus intensity, sound and light discomfort thresholds and pre-attack state. Cephalalgia 2000;20:804-20.
21. Kochar K, Srivastava T, Maurya RK, Jain R, Aggarwal P. Visual evoked potential & brainstem auditory evoked potentials in acute attack & after the attack of migraine. Electromyogr Clin Neurophysiol 2002;42:175-9.
22. Afridi SK, Giffin NJ, Kaube H, et al. A positron emission tomographic study in spontaneous migraine. Arch Neurol 2005;62:1270-5.
23. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;1: 658-60.
24. Holland PR. Modulation of trigeminovascular processing: novel insights into primary headache disorders. Cephalalgia 2009;29(suppl 3):1-6.
25. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614-24.
26. Goadsby PJ, Lipton RB, Ferrari MD. Migraine -current understanding and treatment. N Engl J Med 2002;346:257-70.
27. Harno H, Hirvonen T, Kaunisto MA, et al. Subclinical vestibulocerebellar dysfunction in migraine with and without aura. Neurology 2003;61:1748-52.
28. Hurley LM, Thompson AM, Pollak GD. Serotonin in the inferior colliculus. Hear Res 2002;168:1-11.
29. Murdin L, Premachandra P, Davies R. Sensory dysmodulation in vestibular migraine: an otoacoustic emission suppression study. Laryngoscope 2010;120:1632-6.
30. Szczepaniak WS, Møller AR. Effects of (-)-baclofen, clonazepam, and diazepam on tone exposure-induced hyperexcitability of the inferior colliculus in the rat: possible therapeutic implications for pharmacological management of tinnitus and hyperacusis. Hear Res 1996;97:46-53.
31. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002;58:885-94.